» Articles » PMID: 17182342

HIV in Prison in Low-income and Middle-income Countries

Overview
Date 2006 Dec 22
PMID 17182342
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

High prevalence of HIV infection and the over-representation of injecting drug users (IDUs) in prisons combined with HIV risk behaviour create a crucial public-health issue for correctional institutions and, at a broader level, the communities in which they are situated. However, data relevant to this problem are limited and difficult to access. We reviewed imprisonment, HIV prevalence, and the proportion of prisoners who are IDUs in 152 low-income and middle-income countries. Information on imprisonment was obtained for 142 countries. Imprisonment rates ranged from 23 per 100,000 population in Burkina Faso to 532 per 100,000 in Belarus and Russia. Information on HIV prevalence in prisons was found for 75 countries. Prevalence was greater than 10% in prisons in 20 countries. Eight countries reported prevalence of IDUs in prison of greater than 10%. HIV prevalence among IDU prisoners was reported in eight countries and was greater than 10% in seven of those. Evidence of HIV transmission in prison was found for seven low-income and middle-income countries. HIV is a serious problem for many countries, especially where injection drug use occurs. Because of the paucity of data available, the contribution of HIV within prison settings is difficult to determine in many low-income and middle-income countries. Systematic collection of data to inform HIV prevention strategies in prison is urgently needed. The introduction and evaluation of HIV prevention strategies in prisons are warranted.

Citing Articles

Examining risk factors for HIV infection amongst male inmates in Peruvian prisons: a cross-sectional study using national prisoner census data.

Quispe-Canari J, Carrasco-Navarro R Rev Esp Sanid Penit. 2025; 26(3):82-91.

PMID: 39927805 PMC: 11632554. DOI: 10.18176/resp.00093.


Facilitators and Barriers to adherence to antiretroviral therapy among incarcerated people living with HIV in Iran: insights from a qualitative study.

Bazrafshan A, Rafiei-Rad A, Bazrafshan M, Ghalekhani N, Mehmandoost S, SeyedAlinaghi S Harm Reduct J. 2025; 22(1):4.

PMID: 39773185 PMC: 11708189. DOI: 10.1186/s12954-024-01151-2.


Odds of HIV among incarcerated drug users: a systematic review and meta-analysis of Asian countries.

Ul Hussain H, Ashok Kumar K, Tayyaba Rehan S, Khan Z, Hashmi M, Khabir Y Ann Med Surg (Lond). 2023; 85(11):5584-5592.

PMID: 37915701 PMC: 10617921. DOI: 10.1097/MS9.0000000000001242.


Contributing factors for self-reported HIV in male Peruvian inmates: results of the 2016 prison census.

Culquichicon C, Zapata-Castro L, Soto-Becerra P, Silva-Santisteban A, Konda K, Lescano A Front Public Health. 2023; 11:1241042.

PMID: 37818296 PMC: 10560882. DOI: 10.3389/fpubh.2023.1241042.


Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017-2019 multicenter cross-sectional study.

Maggiorella M, Sernicola L, Picconi O, Pizzi E, Belli R, Fulgenzi D Sci Rep. 2023; 13(1):14908.

PMID: 37689795 PMC: 10492787. DOI: 10.1038/s41598-023-41814-x.